Sonali M. Smith, MD

Articles

Dr. Smith on Unmet Clinical Needs in Indolent Lymphomas

May 22nd 2020

Sonali M. Smith, MD, discusses unmet clinical needs in indolent lymphomas.

Dr. Smith on Unmet Clinical Needs in Indolent Lymphomas

May 21st 2020

Sonali M. Smith, MD, discusses unmet clinical needs in indolent lymphomas.

Dr. Smith on Ongoing Research in Relapsed/Refractory MCL

May 18th 2020

Sonali M. Smith, MD, discusses ongoing research in relapsed/refractory mantle cell lymphoma.

Dr. Smith on Ongoing Research in Relapsed/Refractory MCL

May 18th 2020

Sonali M. Smith, MD, discusses ongoing research in relapsed/refractory mantle cell lymphoma.

Dr. Smith on Frontline Treatment Options in MCL

May 14th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Smith on Frontline Treatment Options in MCL

May 13th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Smith on Safety Profiles of BTK Inhibitors in MCL

May 12th 2020

Sonali M. Smith, MD, discusses the different safety profiles of BTK inhibitors in mantle cell lymphoma.

Dr. Smith on the Guiding Principles for Treating iNHL

February 29th 2020

Sonali M. Smith, MD, discusses the prognosis of patients with indolent non-Hodgkin lymphomas.

Dr. Smith Advises Clinicians on Diagnosing Double-Hit and Triplet-Hit Lymphoma

September 6th 2018

Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, advises clinicians on diagnosing double-hit and triple-hit lymphoma in patients with diffuse large B-cell lymphoma.

Dr. Smith Discusses the Diagnosis of Double-Hit Lymphoma

August 17th 2018

Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, discusses the diagnosis of double-hit lymphoma.

Dr. Smith Discusses Double-Hit and Triple-Hit Lymphoma

July 31st 2018

Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, discusses double-hit and triple-hit lymphoma.

Dr. Smith Discusses Brentuximab Vedotin in CTCL

July 20th 2018

Sonali M. Smith, MD, Elwood V. Jensen Professor in Medicine, director, Lymphoma Program, University of Chicago Medicine, discusses brentuximab vedotin (Adcetris) in cutaneous T-cell lymphoma.